1Yr·

Someone comments on $MRNA (-1.12%) + $MRK (-0.22%) , due to its new clinical trials on cancer vaccine. To visualize its future profile.

1
1 Comment

profile image
Surely, anti-obesity drug gives $LLY and $NVO great profits in 2023. In the past, $PFE and $MRNA gained so much from Covid vaccine in 2021-2022.
Join the conversation